Thank you for your interest!
Standardizing Cryopreservation for a Sustainable Cell Therapy Supply Chain
Cryoport Systems is advancing the cell therapy landscape by incorporating cryopreservation services into our industry-leading supply chain platform. This whitepaper outlines an innovative approach to the delivery of high-quality, consistent cryopreserved leukapheresis, which is commonly used as starting materials for many cell-based therapies.
By integrating cutting-edge bioprocessing technology and cryopreservation methods and leveraging state-of-the-art GMP-compliant cryogenic storage and transportation, Cryoport Systems streamlines the traditional fragmented cell therapy supply chain and effectively mitigates risks associated with the supply and transportation of critical starting materials.